Location: New York NY, Washington D.C. DC, Fairfax VA, Margate FL,
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07128199
Phase 3, Recruiting
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
for
Adenocarcinoma of the Bladder,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06041503
Phase 2, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Lake Success NY, New York NY, Philadelphia PA, Ottawa,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers
for
Malignant Female Reproductive System Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: Female
Age: 18+
Code: NCT07731880
Recruiting
Y-90 Treatment Response Using Transarterial Radioembolization